Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, ...

People with type 2 diabetes using GLP-1s had a lower risk for colorectal cancer than those undergoing bariatric surgery, as well as the general population.

Department of Endocrinology and Metabolism, Affiliated Hospital of Qingdao University, Qingdao 266003, P. R. China Qingdao Key Laboratory of Thyroid, Diseases, Medical Research Center, Qingdao 266555, ...

When patients with solid tumors had the same findings using liquid- and tissue-based tests from Foundation Medicine, patients had better outcomes on molecular tumor board-guided therapy.

The phase II ROME trial demonstrated that personalized therapy guided by combined tissue and liquid biopsies significantly ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

Creative Proteomics announced the launch of a Glycolysis Pathway Analysis platform that incorporates LC-MS/MS metabolomics, stable isotope tracing, and computational flux modeling for a complete ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

Methyl eugenol (ME), a phenylpropanoid compound found in the essential oils of various aromatic plants, has recently garnered attention due to its ...

More information: Jing Gao et al, APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway, Biomolecules and ...

RNA seq results showed significant transcriptome-wide expression alterations regulated by VEL_1243 and VEL_1084, exemplified by their impact on disease-associated signaling pathways including PI3K-Akt ...